Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiration, Artificial | 2 | 2014 | 296 | 0.400 |
Why?
|
| Catheters | 1 | 2012 | 78 | 0.370 |
Why?
|
| Erythrocytes | 7 | 1996 | 150 | 0.360 |
Why?
|
| Intubation, Intratracheal | 1 | 2012 | 203 | 0.330 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 154 | 0.330 |
Why?
|
| Symporters | 2 | 1996 | 18 | 0.240 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1118 | 0.210 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2014 | 73 | 0.200 |
Why?
|
| Potassium | 5 | 1996 | 100 | 0.190 |
Why?
|
| Clotrimazole | 6 | 1996 | 9 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 1996 | 709 | 0.170 |
Why?
|
| Hemolysis | 1 | 1996 | 40 | 0.120 |
Why?
|
| Potassium Channel Blockers | 4 | 1996 | 27 | 0.120 |
Why?
|
| Cations | 1 | 1995 | 64 | 0.110 |
Why?
|
| Antidotes | 1 | 2014 | 18 | 0.110 |
Why?
|
| Poisoning | 1 | 2014 | 31 | 0.110 |
Why?
|
| Infant | 3 | 2014 | 1664 | 0.100 |
Why?
|
| Calcium | 5 | 1996 | 580 | 0.100 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 52 | 0.090 |
Why?
|
| Length of Stay | 2 | 2014 | 819 | 0.090 |
Why?
|
| Anemia, Sickle Cell | 3 | 1996 | 64 | 0.080 |
Why?
|
| Acute Disease | 1 | 2012 | 671 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2014 | 2019 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2012 | 870 | 0.070 |
Why?
|
| Imidazoles | 3 | 1996 | 84 | 0.060 |
Why?
|
| Hospitalization | 1 | 2014 | 1368 | 0.060 |
Why?
|
| Child | 2 | 2014 | 4583 | 0.060 |
Why?
|
| Bumetanide | 2 | 1996 | 3 | 0.060 |
Why?
|
| Reticulocytes | 1 | 2005 | 12 | 0.060 |
Why?
|
| Potassium Channels | 2 | 1996 | 58 | 0.060 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2005 | 23 | 0.060 |
Why?
|
| Mice, Inbred Strains | 2 | 1996 | 192 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2005 | 136 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2014 | 6741 | 0.050 |
Why?
|
| Male | 6 | 2014 | 30322 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5696 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1996 | 490 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 1996 | 3449 | 0.030 |
Why?
|
| Biological Transport | 2 | 1995 | 291 | 0.030 |
Why?
|
| Female | 4 | 2014 | 33383 | 0.030 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 1996 | 2 | 0.030 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1996 | 6 | 0.030 |
Why?
|
| Hypotonic Solutions | 1 | 1996 | 8 | 0.030 |
Why?
|
| Antisickling Agents | 1 | 1996 | 5 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 1996 | 4 | 0.030 |
Why?
|
| Sulfates | 1 | 1996 | 15 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 1996 | 85 | 0.030 |
Why?
|
| Hematocrit | 1 | 1996 | 34 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 1996 | 110 | 0.030 |
Why?
|
| Benzofurans | 1 | 1996 | 13 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 16 | 0.030 |
Why?
|
| Sodium | 1 | 1996 | 61 | 0.030 |
Why?
|
| Scorpion Venoms | 1 | 1995 | 3 | 0.030 |
Why?
|
| Magnesium | 1 | 1996 | 55 | 0.030 |
Why?
|
| Receptors, Drug | 1 | 1995 | 5 | 0.030 |
Why?
|
| Erythrocyte Membrane | 1 | 1995 | 25 | 0.030 |
Why?
|
| Ouabain | 1 | 1995 | 5 | 0.030 |
Why?
|
| Species Specificity | 1 | 1996 | 334 | 0.030 |
Why?
|
| Humans | 10 | 2014 | 64272 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1995 | 230 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1996 | 462 | 0.030 |
Why?
|
| Accidents | 1 | 2014 | 13 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1995 | 155 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 258 | 0.030 |
Why?
|
| New England | 1 | 2014 | 269 | 0.030 |
Why?
|
| Mice | 3 | 1996 | 10994 | 0.030 |
Why?
|
| Suicide, Attempted | 1 | 2014 | 107 | 0.030 |
Why?
|
| Drug Overdose | 1 | 2014 | 122 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 313 | 0.020 |
Why?
|
| Peptides | 1 | 1995 | 590 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2014 | 368 | 0.020 |
Why?
|
| Animals | 4 | 1996 | 20955 | 0.020 |
Why?
|
| Administration, Oral | 3 | 1996 | 374 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 1164 | 0.020 |
Why?
|
| Erythrocyte Indices | 1 | 2005 | 6 | 0.010 |
Why?
|
| Ion Transport | 2 | 1995 | 21 | 0.010 |
Why?
|
| Ferritins | 1 | 2005 | 31 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 288 | 0.010 |
Why?
|
| Kinetics | 2 | 1995 | 766 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 6306 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 3318 | 0.010 |
Why?
|
| Rubidium | 1 | 1995 | 1 | 0.010 |
Why?
|
| Charybdotoxin | 1 | 1995 | 5 | 0.010 |
Why?
|
| Neurotoxins | 1 | 1995 | 22 | 0.010 |
Why?
|
| Imidazoline Receptors | 1 | 1995 | 1 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 1995 | 36 | 0.010 |
Why?
|
| Point Mutation | 1 | 1995 | 165 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 1995 | 46 | 0.010 |
Why?
|
| Rabbits | 1 | 1995 | 333 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 333 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 374 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 869 | 0.010 |
Why?
|
| Triglycerides | 1 | 1995 | 244 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 914 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1995 | 256 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1995 | 1297 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 2237 | 0.000 |
Why?
|
| Adult | 1 | 1995 | 17136 | 0.000 |
Why?
|